These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31598208)

  • 21. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignancy in giant cell tumor of bone in the extremities.
    Liu W; Chan CM; Gong L; Bui MM; Han G; Letson GD; Yang Y; Niu X
    J Bone Oncol; 2021 Feb; 26():100334. PubMed ID: 33251099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of Giant Cell Tumor of the Spine after Resection: A Report of 10 Cases.
    Lin P; Lin N; Teng W; Wang SD; Pan WB; Huang X; Yan XB; Liu M; Li HY; Li BH; Sun LL; Wang Z; Zhou XZ; Ye ZM
    Orthop Surg; 2018 May; 10(2):107-114. PubMed ID: 29878714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrosarcoma development 15 years after curettage and bone grafting of giant cell tumor of bone.
    Li J; Zhu Y; Wei Y
    Orthopedics; 2014 May; 37(5):e512-6. PubMed ID: 24810832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Giant cell tumor of long bone: a Canadian Sarcoma Group study.
    Turcotte RE; Wunder JS; Isler MH; Bell RS; Schachar N; Masri BA; Moreau G; Davis AM;
    Clin Orthop Relat Res; 2002 Apr; (397):248-58. PubMed ID: 11953616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
    BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late malignant transformation of giant cell tumor of bone 41 years after primary surgery.
    Kadowaki M; Yamamoto S; Uchio Y
    Orthopedics; 2012 Oct; 35(10):e1566-70. PubMed ID: 23027500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
    Farfalli GL; Albergo JI; Piuzzi NS; Ayerza MA; Muscolo DL; Ritacco LE; Aponte-Tinao LA
    Clin Orthop Relat Res; 2018 Mar; 476(3):511-517. PubMed ID: 29529633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary malignant giant cell tumor of bone due to malignant transformation 40 years after surgery without radiation therapy, presenting as fever of unknown origin: a case report.
    Takesako H; Osaka E; Yoshida Y; Sugitani M; Tokuhashi Y
    J Med Case Rep; 2016 Mar; 10():47. PubMed ID: 26951080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence Rate of Giant Cell Tumor With the Treatment of Scooping Curettage, Burr Down Technique, Phenolization, and Bone Cement.
    Gillani SFUHS; Iqbal Y; Taqi M; Ahmad Blouch T; Iqbal M; Siddiq A
    Cureus; 2020 Dec; 12(12):e11953. PubMed ID: 33425532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical management for giant cell tumor of bones.
    Khalil el SA; Younis A; Aziz SA; El Shahawy M
    J Egypt Natl Canc Inst; 2004 Sep; 16(3):145-52. PubMed ID: 15959547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
    Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
    Yacob O; Umer M; Gul M; Qadir I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
    Dierselhuis EF; Goulding KA; Stevens M; Jutte PC
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010778. PubMed ID: 30845364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
    World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical studies on effect of bone cement filling on articular cartilage of the knee after curettage of giant cell tumor].
    Cao W; Ye Z; Lin N; Liu M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1459-63. PubMed ID: 25826886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Giant cell tumor of bone in the foot and ankle.
    O'Keefe RJ; O'Donnell RJ; Temple HT; Scully SP; Mankin HJ
    Foot Ankle Int; 1995 Oct; 16(10):617-23. PubMed ID: 8574373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?
    van der Heijden L; van de Sande MA; Heineken AC; Fiocco M; Nelissen RG; Dijkstra PD
    J Bone Joint Surg Am; 2013 Nov; 95(21):e159. PubMed ID: 24196471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.
    Errani C; Tsukamoto S; Leone G; Righi A; Akahane M; Tanaka Y; Donati DM
    J Bone Joint Surg Am; 2018 Mar; 100(6):496-504. PubMed ID: 29557866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.